R multiple myeloma.  Other approvals   The European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation in Europe. Official Comments  Mathai Mammen, M.D., Ph.D.
https://www.tipranks.com/news/janssen-submits-biologics-license-application-for-teclistamab?utm_source=advfn.com&utm_medium=referral
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2022 to May 2022 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From May 2021 to May 2022 Click Here for more Johnson and Johnson Charts.